Adverse Events Occurred at Similar Frequency Across Treatment Groups
PLA SAL50 FP250 FP500 FSC250/50 FSC500/50 n=576 n=341 n=399 n=391 n=178 n=169
Mean Exposure 129 139 136 132 141 138 (days)
Patients with 69 68 74 80 70 78AE (%)
Patients withdrawn 6 4 6 11 5 7due to AE (%)
Patients with 6 4 6 7 4 5SAE (%)